Substance P (SP) (10(-8) M) can rapidly reduce the affinity and increase the density of 3H-5-HT binding sites in spinal cord membranes. CCK-8 and CCK-4 (10(-8) M) can rapidly and differentially change the characteristics of 3H-spiperone striatal binding sites linked to DA receptors of the D2 type. CCK-4 increase and CCK-8 reduce the number of striatal binding sites for 3H-spiperone, indicating for the first time separate CCK-4 binding sites. CCK-4 (10(-8) M) but not CCK-8 (10(-8) M) can rapidly reduce the affinity and increase the number of the 3H-spiperone binding sites linked to 5-HT receptors of the dorsal cerebral cortex of rats. CCK-8 (10(-8) M) only produces a trend for a small increase in the Bmax values of these receptors. These res...
Substance P (SP), a neuropeptide that belongs to the tachykinin family, is widely distributed of th...
Several lines of evidence link the dopaminergic neurotransmitter system to schizophrenia. The antips...
Future therapies for diseases associated with altered dopaminergic signaling, including Parkinson's ...
Substance P (SP) (10(-8) M) can rapidly reduce the affinity and increase the density of 3H-5-HT bind...
Receptor diversity in combination with receptor-receptor subtype specific interactions, which can be...
During recent years a large number of observations have been made indicating that neuropeptides and ...
Many pathological processes are associated with excessive neurotransmitter release that leads to the...
Numerous studies have now demonstrated that a binding site for the psychotomimetic drug phencyclidin...
l-Glutamate but not methyl-D-aspartate (NMDA) or quisqualate ( Quis ) (10(-6 M) in vitro with or wit...
l-Glutamate but not methyl-D-aspartate (NMDA) or quisqualate ( Quis ) (10(-6 M) in vitro with or wit...
dine ([3H]TCP), a derivative of the dissociative anesthetic phencyclidine (PCP), has recently been s...
Evidence has been presented for the existence of interactions between CCK and DA receptors both in s...
Further evidence for the existence of interactions between receptors for dopamine and neurotensin. D...
There is considerable evidence to suggest that dopamine (DA), in addition to its role as a precursor...
We investigated whether neuronal serotonin uptake is regulated by PKC. ($\sp3$H) 5-HT uptake and it...
Substance P (SP), a neuropeptide that belongs to the tachykinin family, is widely distributed of th...
Several lines of evidence link the dopaminergic neurotransmitter system to schizophrenia. The antips...
Future therapies for diseases associated with altered dopaminergic signaling, including Parkinson's ...
Substance P (SP) (10(-8) M) can rapidly reduce the affinity and increase the density of 3H-5-HT bind...
Receptor diversity in combination with receptor-receptor subtype specific interactions, which can be...
During recent years a large number of observations have been made indicating that neuropeptides and ...
Many pathological processes are associated with excessive neurotransmitter release that leads to the...
Numerous studies have now demonstrated that a binding site for the psychotomimetic drug phencyclidin...
l-Glutamate but not methyl-D-aspartate (NMDA) or quisqualate ( Quis ) (10(-6 M) in vitro with or wit...
l-Glutamate but not methyl-D-aspartate (NMDA) or quisqualate ( Quis ) (10(-6 M) in vitro with or wit...
dine ([3H]TCP), a derivative of the dissociative anesthetic phencyclidine (PCP), has recently been s...
Evidence has been presented for the existence of interactions between CCK and DA receptors both in s...
Further evidence for the existence of interactions between receptors for dopamine and neurotensin. D...
There is considerable evidence to suggest that dopamine (DA), in addition to its role as a precursor...
We investigated whether neuronal serotonin uptake is regulated by PKC. ($\sp3$H) 5-HT uptake and it...
Substance P (SP), a neuropeptide that belongs to the tachykinin family, is widely distributed of th...
Several lines of evidence link the dopaminergic neurotransmitter system to schizophrenia. The antips...
Future therapies for diseases associated with altered dopaminergic signaling, including Parkinson's ...